(MENAFN – AsiaNet News) The FDA issued warning letters to 30 telehealth companies over allegedly misleading marketing tied to compounded GLP-1 weight-loss drugs. Investor focus has also shifted to …
Hims Stock Slips Overnight As FDA Warns Telehealth Firms Over GLP-1 Claims – Why Traders Think The ‘Overhang’ Won’t Last
RELATED ARTICLES
